Inspire Medical board member Jerry C. Griffin retiring after 16 years

Inspire Medical Systems, Inc.

Dr. Griffin will retire effective at the conclusion of the 2024 Annual Meeting on May 2, 2024.
He served on the Board since 2008, most recently on the Nominating and Corporate Governance Committee.
Retirement not due to any disagreement with the Company on operations, policies, or practices.
In December 2023, the Board appointed Myriam J. Curet, M.D. (EVP & CMO of Intuitive Surgical) as a new director.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jerry C. Griffin

Director

INSP · Inspire Medical Systems, Inc.

Filed: January 26, 2024, 6:59 PM ET

On January 22, 2024, Jerry C. Griffin, M.D., a member of the Board of Directors (the “Board”) of Inspire Medical Systems, Inc. (the “Company”), notified the Company of his decision to retire from the Board and not stand for re-election at the Company’s 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jerry C. Griffin departed as Director at Inspire Medical Systems, Inc..

Action: retire
Role: Director

Exact text from the filing

On January 22, 2024, Jerry C. Griffin, M.D., a member of the Board of Directors (the “Board”) of Inspire Medical Systems, Inc. (the “Company”), notified the Company of his decision to retire from the Board and not stand for re-election at the Company’s 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”).

View on SEC.gov

Inspire Medical Systems, Inc. filing history →

Source: SEC EDGAR

accession 0001609550-24-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.